Pharmaceutical Drugs And Biologics MGR 2017

TBRC2089
Pages: 350
July 2017
Total Views:1491
Region : Global
The Business Research Company
Market Research Report

Bundle Purchase

Select a License

Single User License

USD 8000

Hard Copy License

USD 8000

Site License

USD 12000

CD-Rom

USD 8000

Corporate User License

USD 16000

Details

The pharmaceuticals industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs for medications. Pharmaceuticals are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing of drugs.

Pharmaceutical companies produce biological products, pharmaceutical preparations and medicinal and botanical products.

The global pharmaceutical market is expected to reach over $1300 billion in 2020. one of the key drivers of the pharmaceuticals market during 2016-2020 is expected to include 'New Methods For Drug Discovery'. Stem cells and organ on chip technologies are changing the way drug trials are being conducted. Organ on chips are micro-engineered biometric systems that simulates activities, mechanics and physiological response of organ systems. Drug trial processes such as target identification, validation, target based screening and phenotypic screening are being done through organ on chip and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Therefore, low drug discovery costs and accurate results generated from these technologies is expected to drive the pharmaceuticals market.

The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.

One of the top trends that is observed in the pharmaceuticals market include 'Turning Away From Animal Testing'. The pharmaceutical industry is moving away from animal testing towards cheaper and more efficient technologies. For example, LiverChip technology created an alternative model of testing which uses a 3D cell culture platform that mimics the architecture and physiology of a human being, which was significantly less expensive and more efficient than animal testing.

The Pharmaceutical Drugs And Biologics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs and biologics sector.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the pharmaceutical drugs and biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs and biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider healthcare market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The pharmaceutical drugs and biologics market section of the report gives context. It compares the pharmaceutical drugs and biologics market with other segments of the healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison.

The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Scope

Markets Covered: Pharmaceuticals, Biologics, Pharmaceutical Drugs

Companies Mentioned: Pfizer, Roche, Glaxosmithkline, Merck & Co., and Sanofi

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Scope

1. Pharmaceutical Drugs And Biologics Market Characteristics;

2. Pharmaceutical Drugs And Biologics Market Size And Growth;

2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; Aging Populations; Emerging Markets Growth; Health Insurance Reforms; 2.1.2. Restraints On The Market; Patent Expiration Of Drugs; Pricing Pressures From Regulators; High Costs Of Drug Approval; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; Economic Growth; Technology; Changes In Lifestyles; New Methods For Drug Discovery; 2.2.2. Restraints On The Market; Cost; Interest Rate Increases; Reduction In Free Trade;

3. Pestle Analysis;

3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Pharmaceutical Drugs And Biologics Market Customer Information;

5. Pharmaceutical Drugs And Biologics Market Segmentation;

5.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 5.2. Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Segment; 5.3 Global Pharmaceutical Drugs And Biologics Market Trends And Strategies; Turning Away From Animal Testing; Increase In Personalized Medicine; Collaboration Driving Innovation; Increase In Mergers And Acquisitions; Rise Of Biologics/Gene Therapy; Aggressive Pricing Changes In Some Drugs; 5.4 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016; 5.5 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012-2020, Historic and Forecast; 5.6 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region; 5.7 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country; 5.8 Pharmaceutical Drugs; 5.8.1. Market Characteristics; 5.8.2. Global Pharmaceutical Drugs Market, 2016, By Segment; 5.8.3. Global Pharmaceutical Drugs Market, 2012-2020, Historic and Forecast, By Segment; 5.8.4. Market Trends And Strategies; 5.9 Biologics; 5.9.1. Market Characteristics; 5.9.2. Global Biologics Market, 2016, By Segment; 5.9.3. Global Biologics Market, 2012-2020, Historic and Forecast, By Segment; 5.9.4. Market Trends And Strategies;

6. Pharmaceutical Drugs And Biologics Market Regional And Country Analysis;

6.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs And Biologics Market, 2016, By Country; 6.4. Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country;

7. Global Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors;

7.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global;

8. Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries;

8.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country;

9. Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics;

9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.6. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.7. Global Average Spending On R&D/Product Development, 2016, By Country; 9.8. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.9. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.10. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.11. Global Number Of Pharmacies, 2016, By Country; 9.12. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country; 9.13. Global New Drug Approvals, 2016, By Country; 9.14. Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country; 9.15. Global Number Of General Practitioners 2016, By Country; 9.16. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country;

10. Asia-Pacific Pharmaceutical Drugs And Biologics Market;

10.1.1. Asia-Pacific Pharmaceutical Drugs And Biologics Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.2. Asia-Pacific Pharmaceutical Drugs And Biologics Market: Country Analysis; 10.3. China Pharmaceutical Drugs And Biologics Market; 10.3.1. China Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.3.2. China Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.3.3. China Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.3.4. China Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.3.5. China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 10.4. India Pharmaceutical Drugs And Biologics Market; 10.4.1. India Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.4.2. India Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.4.3. India Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.4.4. India Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.4.5. India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 10.5. Japan Pharmaceutical Drugs And Biologics Market; 10.5.1. Japan Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.5.2. Japan Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.5.3. Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.5.4. Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.5.5. Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 10.5.7. Japan Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 10.5.7.2. Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 10.6. Australia Pharmaceutical Drugs And Biologics Market; 10.6.1. Australia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.6.2. Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.6.3. Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.6.4. Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020;

11. Western Europe Pharmaceutical Drugs And Biologics Market;

11.1.1. Western Europe Pharmaceutical Drugs And Biologics Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.1.3. Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.1.4. Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.2. Western Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 11.3. UK Pharmaceutical Drugs And Biologics Market; 11.3.1. UK Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 11.3.2. UK Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.3.3. UK Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.3.4. UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.3.5. UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.3.7. UK Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.3.7.1 UK Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.3.7.2 UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.4. Germany Pharmaceutical Drugs And Biologics Market; 11.4.1. Germany Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.4.2. Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.4.3. Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.4.4 Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.4.6 Germany Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.4.7.1 Germany Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.4.7.2 Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.5 France Pharmaceutical Drugs And Biologics Market; 11.5.1 France Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.5.2 France Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.5.3 France Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.5.4 France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.5.6 France Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.5.6.1 France Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.5.6.2 France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6.1. Italy Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.6.2. Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.6.3. Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.6.4. Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.6.6. Italy Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.6.6.1 Italy Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.6.6.2 Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.7. Spain Pharmaceutical Drugs And Biologics Market; 11.7.1. Spain Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.7.2. Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.7.3. Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.7.4. Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.7.6. Spain Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.7.6.1 Spain Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.7.6.2 Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016;

12. Eastern Europe Pharmaceutical Drugs And Biologics Market;

12.1.1. Eastern Europe Pharmaceutical Drugs And Biologics Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 12.1.3. Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 12.1.4 Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.2. Eastern Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs And Biologics Market; 12.3.1. Russia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 12.3.2. Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 12.3.3. Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.3.4. Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020;

13. North America Pharmaceutical Drugs And Biologics Market;

13.1.1. North America Pharmaceutical Drugs And Biologics Market Overview; 13.1.2. North America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 13.1.3. North America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 13.1.4. North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.2. North America Pharmaceutical Drugs And Biologics Market: Country Analysis; 13.3. USA Pharmaceutical Drugs And Biologics Market; 13.3.1. USA Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 13.3.2. USA Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 13.3.3 USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.3.4. USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 13.3.6. USA Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 13.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 13.3.6.2 USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016;

14. South America Pharmaceutical Drugs And Biologics Market;

14.1.1. South America Pharmaceutical Drugs And Biologics Market Overview; 14.1.2. South America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 14.1.3. South America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 14.1.4. South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.2. South America Pharmaceutical Drugs And Biologics Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs And Biologics Market; 14.3.1. Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 14.3.2. Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 14.3.3. Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.3.4. Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020;

15. Middle East Pharmaceutical Drugs And Biologics Market;

15.1.1. Middle East Pharmaceutical Drugs And Biologics Market Overview; 15.1.2. Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 15.1.3. Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 15.1.4. Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs;

16. Africa Pharmaceutical Drugs And Biologics Market;

16.1.1. Africa Pharmaceutical Drugs And Biologics Market Overview; 16.1.2. Africa Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 16.1.3. Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 16.1.4. Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Pharmaceutical Drugs;

17. Pharmaceutical Drugs And Biologics Market Competitive Landscape;

17.1. Company Profiles; 17.2. Pfizer; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Roche; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Glaxosmithkline; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Merck & Co.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Pharmaceutical Drugs And Biologics Market;

19. Market Background: Healthcare Market;

19.1.1. Healthcare Market Characteristics; 19.1.2. Healthcare Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Healthcare Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Healthcare Trends And Strategies; 19.2. Healthcare Market Regional And Country Analysis; 19.2.1. Global Healthcare Market, 2016, By Region; 19.2.2. Global Healthcare Market, 2012-2020, Historic And Forecast, By Region; 19.2.3. Healthcare Market, 2016, By Country; 19.2.4. Healthcare Market, 2012-2020, Historic And Forecast, By Country; 19.2.5. Global Healthcare Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Healthcare Market Comparison With Macro Economic Factors; 19.3.1. Healthcare Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Healthcare Expenditure, Global; 19.4. Healthcare Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Healthcare Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Healthcare Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Healthcare Market;

20. Healthcare Industry Financial Margins;

21. Appendix;

21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer

List Of Figure

Table 1: Global Pharmaceutical Drugs And Biologics Historic Market Growth

Table 2: Global Pharmaceutical Drugs And Biologics Forecast Market Growth

Table 3: Pharmaceutical Drugs And Biologics Market Segmentation

Table 4: Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 5: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Segment

Table 6: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016

Table 7: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012-2020, Historic and Forecast

Table 8: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region

Table 9: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country

Table 10: Global Pharmaceutical Drugs Market, 2016, By Segment

Table 11: Global Pharmaceutical Drugs Market, 2012-2020, Historic and Forecast, By Segment

Table 12: Global Biologics Market, 2016, By Segment

Table 13: Global Biologics Market, 2012-2020, Historic and Forecast, By Segment

Table 14: Global Pharmaceutical Drugs And Biologics Market, 2016, By Region

Table 15: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Region

Table 16: Pharmaceutical Drugs And Biologics Market, 2016, By Country

Table 17: Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Country

Table 18: Global Healthcare Market Segments, 2016, By Region

Table 19: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region

Table 20: Global Healthcare Market Segments, 2016, By Country

Table 21: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country

Table 22: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global

Table 23: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global

Table 24: Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries

Table 25: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country

Table 26: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country

Table 27: Global Number Of Pharmacists, 2016, By Country

Table 28: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country

Table 29: Global Average Salaries Of Pharmacists, 2016, By Country

Table 30: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Salaries Of Pharmacists, 2016, By Country

Table 31: Global Number Of Pharma Enterprises, 2016, By Country

Table 32: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Table 33: Global Number Of Employees In Pharmaceutical Industry, 2016, By Country

Table 34: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country

Table 35: Global Average Spending On R&D/Product Development, 2016, By Country

Table 36: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Table 37: Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country

Table 38: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country

Table 39: Global Number Of Pharmacies, 2016, By Country

Table 40: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country

Table 41: Global New Drug Approvals, 2016, By Country

Table 42: Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country

Table 43: Global Number Of General Practitioners 2016, By Country

Table 44: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country

Table 45: Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 46: Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 47: Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 48: China Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 49: China Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 50: China Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 51: China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 52: China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 53: India Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 54: India Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 55: India Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 56: India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 57: India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 58: Japan Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 59: Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 60: Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 61: Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 62: Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 63: Japan Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 64: Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 65: Australia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 66: Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 67: Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 68: Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 69: Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 70: Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 71: Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 72: Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 73: UK Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 74: UK Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 75: UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 76: UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 77: UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 78: UK Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 79: UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 80: Germany Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 81: Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 82: Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 83: Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 84: Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 85: Germany Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 86: Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 87: France Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 88: France Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 89: France Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 90: France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 91: France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 92: France Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 93: France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 94: Italy Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 95: Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 96: Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 97: Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 98: Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 99: Italy Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 100: Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 101: Spain Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 102: Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 103: Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 104: Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 105: Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 106: Spain Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 107: Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 108: Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 109: Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 110: Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 111: Russia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 112: Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 113: Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 114: Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 115: Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 116: North America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 117: North America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 118: North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 119: USA Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 120: USA Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 121: USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 122: USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 123: USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 124: USA Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 125: USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Table 126: South America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 127: South America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 128: South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 129: Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 130: Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 131: Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 132: Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Table 133: Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Table 134: Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 135: Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 136: Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 137: Africa Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Table 138: Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Table 139: Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Table 140: Pfizer Financial Performance

Table 141: Roche Financial Performance

Table 142: Glaxosmithkline Financial Performance

Table 143: Merck & Co. Financial Performance

Table 144: Sanofi Financial Performance

Table 145: Healthcare Market Historic Growth

Table 146: Healthcare Market Forecast Growth

Table 147: Global Healthcare Market, 2016, By Region

Table 148: Global Healthcare Market, 2012-2020, Historic And Forecast, By Region

Table 149: Healthcare Market, 2016, By Country

Table 150: Healthcare Market, 2012-2020, Historic And Forecast, By Country

Table 151: Global Healthcare Market, Growth And Market Share Comparison, By Segment

Table 152: Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment

Table 153: Healthcare Market Size, Percentage Of GDP, Global

Table 154: Per Capita Average Healthcare Expenditure, Global

Table 155: Healthcare Market Comparison With Macro Economic Factors Across Countries

Table 156: Healthcare Market Size, Percentage Of GDP, By Country

Table 157: Per Capita Average Healthcare Expenditure, By Country

Table 158: Healthcare Industry Financial Margins

List Of Table

Figure 1: Global Pharmaceutical Drugs And Biologics Historic Market Growth

Figure 2: Global Pharmaceutical Drugs And Biologics Forecast Market Growth

Figure 3: Pharmaceutical Drugs And Biologics Market Segmentation

Figure 4: Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 5: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Segment

Figure 6: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016

Figure 7: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012-2020, Historic and Forecast

Figure 8: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region

Figure 9: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country

Figure 10: Global Pharmaceutical Drugs Market, 2016, By Segment

Figure 11: Global Pharmaceutical Drugs Market, 2012-2020, Historic and Forecast, By Segment

Figure 12: Global Biologics Market, 2016, By Segment

Figure 13: Global Biologics Market, 2012-2020, Historic and Forecast, By Segment

Figure 14: Global Pharmaceutical Drugs And Biologics Market, 2016, By Region

Figure 15: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Region

Figure 16: Pharmaceutical Drugs And Biologics Market, 2016, By Country

Figure 17: Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Country

Figure 18: Global Healthcare Market Segments, 2016, By Region

Figure 19: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region

Figure 20: Global Healthcare Market Segments, 2016, By Country

Figure 21: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country

Figure 22: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global

Figure 23: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global

Figure 24: Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries

Figure 25: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country

Figure 26: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country

Figure 27: Global Number Of Pharmacists, 2016, By Country

Figure 28: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country

Figure 29: Global Average Salaries Of Pharmacists, 2016, By Country

Figure 30: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Salaries Of Pharmacists, 2016, By Country

Figure 31: Global Number Of Pharma Enterprises, 2016, By Country

Figure 32: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Figure 33: Global Number Of Employees In Pharmaceutical Industry, 2016, By Country

Figure 34: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country

Figure 35: Global Average Spending On R&D/Product Development, 2016, By Country

Figure 36: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Figure 37: Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country

Figure 38: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country

Figure 39: Global Number Of Pharmacies, 2016, By Country

Figure 40: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country

Figure 41: Global New Drug Approvals, 2016, By Country

Figure 42: Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country

Figure 43: Global Number Of General Practitioners 2016, By Country

Figure 44: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country

Figure 45: Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 46: Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 47: Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 48: China Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 49: China Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 50: China Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 51: China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 52: China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 53: India Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 54: India Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 55: India Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 56: India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 57: India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 58: Japan Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 59: Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 60: Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 61: Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 62: Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 63: Japan Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 64: Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 65: Australia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 66: Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 67: Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 68: Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 69: Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 70: Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 71: Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 72: Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 73: UK Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 74: UK Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 75: UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 76: UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 77: UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 78: UK Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 79: UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 80: Germany Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 81: Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 82: Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 83: Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 84: Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 85: Germany Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 86: Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 87: France Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 88: France Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 89: France Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 90: France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 91: France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 92: France Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 93: France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 94: Italy Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 95: Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 96: Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 97: Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 98: Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 99: Italy Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 100: Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 101: Spain Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 102: Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 103: Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 104: Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 105: Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 106: Spain Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 107: Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 108: Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 109: Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 110: Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 111: Russia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 112: Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 113: Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 114: Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 115: Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 116: North America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 117: North America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 118: North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 119: USA Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 120: USA Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 121: USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 122: USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 123: USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 124: USA Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 125: USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016

Figure 126: South America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 127: South America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 128: South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 129: Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 130: Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 131: Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 132: Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020

Figure 133: Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020

Figure 134: Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 135: Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 136: Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 137: Africa Pharmaceutical Drugs And Biologics Historic Market, 2012-2016

Figure 138: Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020

Figure 139: Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment

Figure 140: Pfizer Financial Performance

Figure 141: Roche Financial Performance

Figure 142: Glaxosmithkline Financial Performance

Figure 143: Merck & Co. Financial Performance

Figure 144: Sanofi Financial Performance

Figure 145: Healthcare Market Historic Growth

Figure 146: Healthcare Market Forecast Growth

Figure 147: Global Healthcare Market, 2016, By Region

Figure 148: Global Healthcare Market, 2012-2020, Historic And Forecast, By Region

Figure 149: Healthcare Market, 2016, By Country

Figure 150: Healthcare Market, 2012-2020, Historic And Forecast, By Country

Figure 151: Global Healthcare Market, Growth And Market Share Comparison, By Segment

Figure 152: Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment

Figure 153: Healthcare Market Size, Percentage Of GDP, Global

Figure 154: Per Capita Average Healthcare Expenditure, Global

Figure 155: Healthcare Market Comparison With Macro Economic Factors Across Countries

Figure 156: Healthcare Market Size, Percentage Of GDP, By Country

Figure 157: Per Capita Average Healthcare Expenditure, By Country

Figure 158: Healthcare Industry Financial Margins

Licence Rights

Single User License (for access by one person)
Site License (for access of one office location of a company)
Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Biologics, Pharmaceutical Drugs

Companies

Pfizer, Roche, Glaxosmithkline, Merck & Co., and Sanofi

Company Profile

Company Profile Title

Single User Licence

USD 200

Corporate User Licence

USD 500